The role of leukotriene modifiers in the treatment of asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 5 PART I, 1998, Pages 1363-1371

  Horwitz, Randy J ^a   McGill, Kelly A ^a   Busse, William W ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [3 [5 (4 FLUOROPHENOXY) 2 FURYL] 1 METHYL 2 PROPYNYL] 1 HYDROXYUREA; 2 CYCLOPENTYL 2 [4 (2 QUINOLINYLMETHOXY)PHENYL]ACETIC ACID; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 (2 QUINOLINYLMETHOXY) 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 6 [[3 FLUORO 5 (3,4,5,6 TETRAHYDRO 4 METHOXY 2H PYRAN 4 YL)]PHENOXYMETHYL] 1 METHYL 2 QUINOLONE; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MONTELUKAST; PRANLUKAST; TOMELUKAST; VERLUKAST; ZAFIRLUKAST; ZILEUTON;

ASTHMA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DYSPEPSIA; EXERCISE INDUCED ASTHMA; FEMALE; HEADACHE; HUMAN; IMMUNOMODULATION; INHALATIONAL DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW;

EID: 0031779165     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.5.9706059     Document Type: Article

References (16)

1. Bousquet, J., P. Chenz, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F. B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
2. Samuelsson, B., S. E. Dahlen, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237:1171-1176.
3. Lewis, R. A., K. F. Austen, and R. J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323:645-655.
4. 4 synthase at nuclear membrane. Am. J. Respir. Crit. Care Med. 152:283-289.
5. 4, and histamine in normal human subjects. Thorax 39:500-504.
6. 4 enhance histamine responsiveness in asthmatic airways. Am. Rev. Respir. Dis. 144:1053-1057.
7. Wenzel, S. E., J. B. Trudeau, D. A. Kaminsky, J. Cohn, R. J. Martin, and J. Y. Westcott. 1995. Effect of 5-lipoxygenase inhibition of bronchoconstriction and airway inflammation in nocturnal asthma. Am. J. Respir. Crit. Care Med. 152:897-905.
8. Israel, E., A. R. Fischer, M. A. Rosenberg, C. M. Lilly, J. C. Gallery, J. Shapiro, J. Cohn, P. Rubin, and J. M. Drazen. 1993. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am. Rev. Respir. Dis. 148:1447-1451.
9. Hui, K. P., I. K. Taylor, G. W. Taylor, P. Rubin, J. Kesterson, N. C. Barnes, and P. J. Barnes. 1991. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 46:184-189.
10. Yamaoka, K. A., and J. P. Kolb. 1993. Leukotriene B4 induces interleukin 5 generation from human T lymphocytes. Eur. J. Immunol. 23: 2392-2398.
11. Rouzer, C. A., A. W. Ford-Hutchinson, H. E. Morton, and J. W. Gillard. 1990. MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J. Biol. Chem. 265:1436-1442.
12. 4 antagonists. Curr. Opin. Invest. Drugs 3:13-22.
13. Coleman, R. A., R. M. Eglen, R. L. Jones, S. Narumiya, T. Shimizu, W. L. Smith, S. E. Dahlen, J. M. Drazen, P. J. Gardiner, W. T. Jackson, T. R. Jones, R. D. Krell, and S. Nicosia. 1995. Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. Adv. Prostaglandin Thromboxane Leukotriene Res. 23:283-285.
14. Labat, C., J. L. Ortiz, X. Norel, I. Gorenne, J. Verley, T. S. Abram, N. J. Cuthbert, S. R. Tudhope, P. Norman, P. Gardiner, and C. Brink. 1992. A second cysteinyl leukotriene receptor in human lung. J. Pharmacol. Exp. Ther. 263:800-505.
15. Aalbers, R., H. F. Kauffman, B. Vrugt, M. Smith, G. H. Koeter, W. Timens, and J. G. DeMonchy. 1993. Bronchial lavage and bronchoalveolar lavage in allergen-induced single early and dual asthmatic responders. Am. Rev. Respir. Dis. 147:76-81.
16. Taylor, I., K. O'Shaughnessy, R. Fuller, and C. Dollery. 1991. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperactivity in atopic subjects. Lancet 337:690-694.